| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 96025-47-7 | 2-Methylpropanoic acid 4-[2-[methyl(phenylmethyl)amino]ethyl]-1,2-phenylene ester | C24H31NO4 |
| 96027-03-1 | O(4)-Ethylthymidine 5'-Triphosphate | C12H21N2O14P3 |
| 96027-30-4 | L-Glutaminyl-L-Asparaginyl-L-Cysteinyl-L-Prolyl-L-Arginyl-Glycinamide | C25H44N12O8S |
| 96027-42-8 | 1-(2-Hydroxyethoxymethyl)-6-Azauracil | C6H9N3O4 |
| 96027-62-2 | 1-O-(6-Aminohexanoyl)-2,3-Diphosphoglycerol | C9H21NO10P2 |
| 96027-74-6 | (2-Butylbenzofuran-3-yl)(4-(2-(ethylamino)ethoxy)-3,5-diiodophenyl)methanone hydrochloride | C23H25I2NO3.HCl |
| 96027-84-8 | 2-n-Butyl-4-[(2-bromoethoxy)-3,5-diiodobenzoyl]benzofuran | C21H19BrI2O3 |
| 96028-18-1 | 2-(4-(2,2-Dichlorovinyl)Phenyl)Propionic Acid | C11H10Cl2O2 |
| 96034-57-0 | (2S,4R)-1-(4-Nitrobenzyloxycarbonyl)-4-hydroxyproline | C13H14N2O7 |
| 96034-64-9 | Side chain for meropenem | C15H19N3O5S |
| 96036-02-1 | Protected meropenem | C32H35N5O11S |
| 96036-03-2 | Meropenem | C17H25N3O5S |
| 96036-10-1 | (5-Dimethylaminocarbonylpyrrolidin-3-Ylthio)-6-(1-Hydroxyethyl)Penem-3-Carboxylic Acid | C15H21N3O5S2 |
| 96037-95-5 | (R)-alpha-Amino-1-pyrenepropanoic acid | C19H15NO2 |
| 96038-80-1 | Methyl 2-deoxy-alpha-D-threo-pentofuranoside | C6H12O4 |
| 96038-87-8 | Eleutheroside E | C34H46O18 |
| 96043-39-9 | 2-Isopropenyl-2-methylcyclopropanecarbonyl chloride | C8H11ClO |
| 96047-32-4 | 3-Fluoro-4-Methoxybenzyl Alcohol | C8H9FO2 |
| 96048-73-6 | 1-Chloro-2,5-dimethyl-1H-benzimidazole | C9H9ClN2 |
| 96048-80-5 | 1,4,6-Trimethyl-1H-benzimidazole | C10H12N2 |
| 96049-52-4 | 3-[[(1,1-Dimethylethoxy)Carbonyl]Amino]-Propanethioicacid | C8H15NO3S |
| 96053-20-2 | 4-(Aminomethyl)-3-Methoxy-Benzoic Acid | C9H11NO3 |
| 96054-52-3 | N-Hydroxy-4-pyridazinecarboxamide | C5H5N3O2 |
| 96055-45-7 | Nicotine polacrilex | |
| 96056-51-8 | 2-Benzyl-4-Oxo-5,5,5,-Trifluoropentanoic Acid | C12H11F3O3 |
| 96056-64-3 | (S)-(-)-Indoline-2-carboxylic acid | C9H9NO2 |
| 96059-83-5 | 17-O-Acetyl 19-Normethandriol | C21H32O3 |
| 96062-89-4 | N-(3-Dimethylaminopropyl)-2-(2-Methoxy-4-Prop-2-Enyl-Phenoxy)-2-MethylPropanamide | C19H30N2O3 |
| 96064-42-5 | 1-[3-(Dipropylamino)Propanoyl]-4-Phenyl-Piperidine-4-Carbaldehyde | C21H32N2O2 |
| 96064-46-9 | N-[2-(Hexahydro-1H-Azepin-1-Yl)Ethyl]Phenylethylmalonamidic Acid Ethyl Ester | C21H32N2O3 |
| 96067-93-5 | Benzyl 4-[hydroxy(diphenyl)methyl]-1-piperidinecarboxylate | C26H27NO3 |
| 96077-04-2 | 1-[1-(1-Propoxypropoxy)propoxy]-1-propanol | C12H26O4 |
| 96078-22-7 | 2-[(4-Methyl-2-oxo-2H-chromen-6-yl)oxy]propanoic acid | C13H12O5 |
| 96081-16-2 | Insulin-Like Growthfactor II (Human) | |
| 96081-74-2 | 1,2-Diaminocyclohexaneplatinum II Citrate | C24H50N6O7Pt3 |
| 96081-75-3 | Platuran | C18H38N4O8Pt2 |
| 96082-02-9 / 102068-89-3 | 2-Ethyl-2-Hydroxymethyl-1,3-Propanediol Trimethacrylate | C18H26O6 |
| 96084-09-2 | 4-(Methyl-T3)-L-Norvaline-3,3,4,5,5,5-T6 | |
| 96086-52-1 | Methyl 1,2,3,4-Tetrahydro-3-Hydroxymethyl-beta-Carboline-2-Carbodithioate | C14H16N2OS2 |
| 96086-67-8 / 96086-68-9 | 1,5-Dihydro-7-(1-Piperidinyl)-Imidazo[2,1-b]Quinazolin-2(3H)-One | C15H20Cl2N4O |
| 96087-10-4 | Massoniresinol | C20H24O8 |
| 96087-21-7 | Stylopine hydrochloride | C19H18ClNO4 |
| 96087-24-0 | 3-Spirooxiranylpregnan-20-Ol | C22H36O2 |
| 96087-34-2 | 5(6)-Epoxyprostaglandin F1 Alpha | C20H34O6 |
| 96087-37-5 | N-(4-Azido-2-Nitrophenyl)-N'-(3-Biotinylamino-Propyl)-N'-Methyl-1,3-Propanediamine Acetate Salt | C23H35N9O4S |
| 96087-38-6 | N-{3-[{3-[(4-Azido-2-nitrophenyl)amino]propyl}(methyl)amino]propyl}-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide acetate (1:1) | C25H39N9O6S |
| 96090-00-5 | 2-(N-Piperidine)Ethylamine-1-Naphthyl-5-Sulfonyl chloride | C17H21ClN2O2S |
| 96093-41-3 | (4R,5S)-3-Acetyl-4-methyl-5-phenyl-1,3-oxazolidin-2-one | C12H13NO3 |
| 96093-49-1 | 4-Amino-4,5-dihydro-2-furancarboxylic acid | C5H7NO3 |
| 96096-52-5 | N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-2-propanamine | C14H20N2 |